When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GMAB - J&J's Darzalex OK'd in Japan for first-line multiple myeloma
Genmab A/S
Japan's Ministry of Health, Labor and Welfare approves Johnson & Johnson (NYSE:JNJ) unit Janssen Biotech's Darzalex (daratumumab), combined with Takeda's Velcade (bortezomib), melphalan and prednisone, for newly diagnosed multiple myeloma (MM) patients who are ineligible for autologous stem cell transplant.
More news on: Johnson & Johnson, Genmab A/S, Genmab A/S, Healthcare stocks news,